News Focus
News Focus
icon url

Whalatane

11/06/16 4:52 PM

#95305 RE: VuBru #95304

Vu. Thx for sharing

Did she have any opinion on chances of a stop at Interim 2 ..:-)
Kiwi
icon url

jessellivermore

11/06/16 6:14 PM

#95307 RE: VuBru #95304

VuBru

Now you've really hurt my feelings...

" After further discussion, as an omega-3 expert, she opined that it is highly likely that the R-I trial with pure EPA will succeed (despite her losing her job due to the AMRN patent victory). She stated that the high purity and high dose (4 gram) of V were key for efficacy in her view.

Thought you were taking my opinion on the subject...":>)

Good story...The case for EPA (in 4 gm/doses..((invest))..Is very compelling because the evidence at the cellular level lines up with the clinical effects..

Once R-I results are in it will not take the medical profession very long to "GET IT"..Doctors I talk to are very impressed...

":>) JL
icon url

zumantu

11/06/16 7:32 PM

#95310 RE: VuBru #95304

VuBru, thanks for sharing. I'm sure you were quite amused
icon url

couldbebetter

11/06/16 8:50 PM

#95313 RE: VuBru #95304

VuBru, One question that comes to mind is if BP knows that AMRN has a strong patent position and that Pure EPA at the right dose works, does it not follow that they would consider AMRN to be a takeover candidate? My point being that if this view is shared across BP then AMRN has set itself in a very good position. Most Interesting. Thanks for sharing your story.
icon url

Biobillionair

11/06/16 10:28 PM

#95315 RE: VuBru #95304

I assume she was an Omthera employee? Yes/no
Thanks
BB

I have some questions for you if you don't mind.
icon url

biowreck

11/07/16 7:42 AM

#95324 RE: VuBru #95304

That's encouraging but based on the pps, that view doesn't seem to be shared amongst the medical and bp community otherwise it would be much higher....however it certainly works for me!